Supplementary Figure S1 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Authors: Enriqueta Felip, Peiwen Kuo, Pilar Garrido et al.

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:p><p>Kaplan-Meier plots for OS by treatment arm for the (A) ITT, (B) Trop-2 biomarker evaluable population, and (C) ctDNA biomarker evaluable population.</p></jats:p>

Keywords

biomarker evaluable pkaplanmeier plots treatment

Supplementary Figure S1 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Abstract

Keywords

Related Articles

Multidimensional characteristics and ecological risks of MPs in receiving waters from WWTP effluent

Figure 4 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Charting the small-molecule universe from mass spectra with neuro-symbolic AI

Supplementary Figure S5 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Two new species of Trichoderma from agricultural soils in China